TokyoOne receptor, two separable signals.
Researchers imaged the immune-cell receptor GPR84 in active and inactive states, showing how a drug triggers one pathway while sparing another.
The structures give drug designers a template for anti-inflammatory therapies that keep the benefit and drop the side effects.
Sources: Nature